Novel imaging modalities in gynecologic cancer

被引：0
作者：
Rebecca A. Brooks
Matthew A. Powell
机构：
[1] Washington University School of Medicine,Division of Gynecologic Oncology, Department of Obstetrics and Gynecology
来源：
Current Oncology Reports | 2009年 / 11卷
关键词：
Positron Emission Tomography; Cervical Cancer; Standardize Uptake Value; Uterine Cancer; Recurrent Ovarian Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Novel imaging modalities continue to emerge in medicine, and the advent of 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) has had a significant impact in the imaging of gynecologic malignancies. In cervical cancer, FDG-PET has excellent sensitivity and specificity for evaluation of initial disease, as well as assessment of post-treatment response and long-term surveillance. In ovarian cancer, FDG-PET can be a useful tool in assessing recurrent disease, especially in the setting of a rising cancer antigen-125 with a negative or equivocal CT or MRI. In uterine cancer, FDG-PET has been investigated in evaluating the extent of disease including nodal metastases, and in assessing recurrence. This article reviews novel imaging modalities in gynecologic cancer, with a special focus on FDG-PET/CT.
引用
收藏
页码：466 / 472
页数：6
相关论文
共 179 条
[1]  
Jemal A.(2009)Cancer statistics, 2009 CA Cancer J Clin 59 225-249
[2]  
Siegel R.(2006)Positron-emission tomography and assessment of cancer therapy N Engl J Med 354 496-507
[3]  
Ward E.(2004)Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT J Nucl Med 45 266-271
[4]  
Juweid M.E.(2005)Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers Eur J Nucl Med Mol Imaging 32 549-556
[5]  
Cheson B.D.(2005)Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle Eur J Nucl Med Mol Imaging 32 757-763
[6]  
Lerman H.(2005)Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes Gynecol Oncol 99 294-300
[7]  
Metser U.(2007)Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence Eur J Nucl Med Mol Imaging 34 472-479
[8]  
Grisaru D.(2003)Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT Gynecol Oncol 90 519-528
[9]  
Nishizawa S.(2003)Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET J Nucl Med 44 1051-1056
[10]  
Inubushi M.(2001)Clinical value of positron emission tomography with FDG for recurrent ovarian cancer AJR Am J Roentgenol 176 1449-1454
12345678910